Report Detail
Global Influenza Vaccine Market Professional Survey Report 2019
- RnM3722080 |
- 03 September, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Influenza vaccines are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza.
The European Centre for Disease Prevention and Control also recommends yearly vaccination of high risk groups. These groups include pregnant women, the elderly, children between six months and five years of age, those with other health problems, and those who work in healthcare.
The global Influenza Vaccine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Influenza Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Influenza Vaccine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Influenza Vaccine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Influenza Vaccine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
AstraZeneca
CSL
GlaxoSmithKline
Sanofi
Altimmune
BionVax
FluGen
Folia Biotech
Genentech
Green Cross
Medicago
Moderna Therapeutics
Novavax
Shijiazhuang Yiling Pharmaceutical
SK Chemicals
UNM Pharma
Vaccitec
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Fluzone/Vaxigrip
FluMist
Fluarix and Flulaval
Anflu
Fluvax/Afluria
Flucelvax and Fluvirin
Segment by Application
Adults
Pediatrics
Senior Citizens
Table of Contents
Executive Summary
1 Industry Overview of Influenza Vaccine
- 1.1 Definition of Influenza Vaccine
- 1.2 Influenza Vaccine Segment by Type
- 1.2.1 Global Influenza Vaccine Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Fluzone/Vaxigrip
- 1.2.3 FluMist
- 1.2.4 Fluarix and Flulaval
- 1.2.5 Anflu
- 1.2.6 Fluvax/Afluria
- 1.2.7 Flucelvax and Fluvirin
- 1.3 Influenza Vaccine Segment by Applications
- 1.3.1 Global Influenza Vaccine Consumption Comparison by Applications (2014-2025)
- 1.3.2 Adults
- 1.3.3 Pediatrics
- 1.3.4 Senior Citizens
- 1.4 Global Influenza Vaccine Overall Market
- 1.4.1 Global Influenza Vaccine Revenue (2014-2025)
- 1.4.2 Global Influenza Vaccine Production (2014-2025)
- 1.4.3 North America Influenza Vaccine Status and Prospect (2014-2025)
- 1.4.4 Europe Influenza Vaccine Status and Prospect (2014-2025)
- 1.4.5 China Influenza Vaccine Status and Prospect (2014-2025)
- 1.4.6 Japan Influenza Vaccine Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Influenza Vaccine Status and Prospect (2014-2025)
- 1.4.8 India Influenza Vaccine Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Influenza Vaccine
- 2.3 Manufacturing Process Analysis of Influenza Vaccine
- 2.4 Industry Chain Structure of Influenza Vaccine
3 Development and Manufacturing Plants Analysis of Influenza Vaccine
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Influenza Vaccine Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Influenza Vaccine
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Influenza Vaccine Production and Capacity Analysis
- 4.2 Influenza Vaccine Revenue Analysis
- 4.3 Influenza Vaccine Price Analysis
- 4.4 Market Concentration Degree
5 Influenza Vaccine Regional Market Analysis
- 5.1 Influenza Vaccine Production by Regions
- 5.1.1 Global Influenza Vaccine Production by Regions
- 5.1.2 Global Influenza Vaccine Revenue by Regions
- 5.2 Influenza Vaccine Consumption by Regions
- 5.3 North America Influenza Vaccine Market Analysis
- 5.3.1 North America Influenza Vaccine Production
- 5.3.2 North America Influenza Vaccine Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Influenza Vaccine Import and Export
- 5.4 Europe Influenza Vaccine Market Analysis
- 5.4.1 Europe Influenza Vaccine Production
- 5.4.2 Europe Influenza Vaccine Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Influenza Vaccine Import and Export
- 5.5 China Influenza Vaccine Market Analysis
- 5.5.1 China Influenza Vaccine Production
- 5.5.2 China Influenza Vaccine Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Influenza Vaccine Import and Export
- 5.6 Japan Influenza Vaccine Market Analysis
- 5.6.1 Japan Influenza Vaccine Production
- 5.6.2 Japan Influenza Vaccine Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Influenza Vaccine Import and Export
- 5.7 Southeast Asia Influenza Vaccine Market Analysis
- 5.7.1 Southeast Asia Influenza Vaccine Production
- 5.7.2 Southeast Asia Influenza Vaccine Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Influenza Vaccine Import and Export
- 5.8 India Influenza Vaccine Market Analysis
- 5.8.1 India Influenza Vaccine Production
- 5.8.2 India Influenza Vaccine Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Influenza Vaccine Import and Export
6 Influenza Vaccine Segment Market Analysis (by Type)
- 6.1 Global Influenza Vaccine Production by Type
- 6.2 Global Influenza Vaccine Revenue by Type
- 6.3 Influenza Vaccine Price by Type
7 Influenza Vaccine Segment Market Analysis (by Application)
- 7.1 Global Influenza Vaccine Consumption by Application
- 7.2 Global Influenza Vaccine Consumption Market Share by Application (2014-2019)
8 Influenza Vaccine Major Manufacturers Analysis
- 8.1 AstraZeneca
- 8.1.1 AstraZeneca Influenza Vaccine Production Sites and Area Served
- 8.1.2 AstraZeneca Product Introduction, Application and Specification
- 8.1.3 AstraZeneca Influenza Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 CSL
- 8.2.1 CSL Influenza Vaccine Production Sites and Area Served
- 8.2.2 CSL Product Introduction, Application and Specification
- 8.2.3 CSL Influenza Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 GlaxoSmithKline
- 8.3.1 GlaxoSmithKline Influenza Vaccine Production Sites and Area Served
- 8.3.2 GlaxoSmithKline Product Introduction, Application and Specification
- 8.3.3 GlaxoSmithKline Influenza Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Sanofi
- 8.4.1 Sanofi Influenza Vaccine Production Sites and Area Served
- 8.4.2 Sanofi Product Introduction, Application and Specification
- 8.4.3 Sanofi Influenza Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Altimmune
- 8.5.1 Altimmune Influenza Vaccine Production Sites and Area Served
- 8.5.2 Altimmune Product Introduction, Application and Specification
- 8.5.3 Altimmune Influenza Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 BionVax
- 8.6.1 BionVax Influenza Vaccine Production Sites and Area Served
- 8.6.2 BionVax Product Introduction, Application and Specification
- 8.6.3 BionVax Influenza Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 FluGen
- 8.7.1 FluGen Influenza Vaccine Production Sites and Area Served
- 8.7.2 FluGen Product Introduction, Application and Specification
- 8.7.3 FluGen Influenza Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Folia Biotech
- 8.8.1 Folia Biotech Influenza Vaccine Production Sites and Area Served
- 8.8.2 Folia Biotech Product Introduction, Application and Specification
- 8.8.3 Folia Biotech Influenza Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Genentech
- 8.9.1 Genentech Influenza Vaccine Production Sites and Area Served
- 8.9.2 Genentech Product Introduction, Application and Specification
- 8.9.3 Genentech Influenza Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Green Cross
- 8.10.1 Green Cross Influenza Vaccine Production Sites and Area Served
- 8.10.2 Green Cross Product Introduction, Application and Specification
- 8.10.3 Green Cross Influenza Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Medicago
- 8.12 Moderna Therapeutics
- 8.13 Novavax
- 8.14 Shijiazhuang Yiling Pharmaceutical
- 8.15 SK Chemicals
- 8.16 UNM Pharma
- 8.17 Vaccitec
9 Development Trend of Analysis of Influenza Vaccine Market
- 9.1 Global Influenza Vaccine Market Trend Analysis
- 9.1.1 Global Influenza Vaccine Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Influenza Vaccine Regional Market Trend
- 9.2.1 North America Influenza Vaccine Forecast 2019-2025
- 9.2.2 Europe Influenza Vaccine Forecast 2019-2025
- 9.2.3 China Influenza Vaccine Forecast 2019-2025
- 9.2.4 Japan Influenza Vaccine Forecast 2019-2025
- 9.2.5 Southeast Asia Influenza Vaccine Forecast 2019-2025
- 9.2.6 India Influenza Vaccine Forecast 2019-2025
- 9.3 Influenza Vaccine Market Trend (Product Type)
- 9.4 Influenza Vaccine Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Influenza Vaccine Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Influenza Vaccine. Industry analysis & Market Report on Influenza Vaccine is a syndicated market report, published as Global Influenza Vaccine Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Influenza Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
